T 0308/99 (Hyaluronan/BIOMATRIX) of 2.6.2003

European Case Law Identifier: ECLI:EP:BA:2003:T030899.20030602
Date of decision: 02 June 2003
Case number: T 0308/99
Application number: 86306046.3
IPC class: A61K 47/36
Language of proceedings: EN
Distribution: C
Download and more information:
Decision text in EN (PDF, 58 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: Drug delivery systems based on hyaluronan, derivatives thereof and their salts and method of producing same
Applicant name: Biomatrix, Inc.
Opponent name: Biomatrix Inc.
FIDIA, S.p.A.
Board: 3.3.02
Headnote: -
Relevant legal provisions:
European Patent Convention 1973 Art 52(1)
European Patent Convention 1973 Art 54
European Patent Convention 1973 Art 56
European Patent Convention 1973 Art 83
European Patent Convention 1973 Art 84
European Patent Convention 1973 Art 100
European Patent Convention 1973 Art 111(1)
European Patent Convention 1973 Art 123(2)
European Patent Convention 1973 Art 123(3)
European Patent Convention 1973 R 57a
Keywords: Novelty (yes): claimed use reflects a newly discovered technical effect
Inventive step (no): claimed use is based on a thoroughly obvious property of known substances; slightly enhanced effects associated with the claimed use in comparision with substances used in the state of the art emerge from obvious tests - no indication of an inventive step
Catchwords:

-

Cited decisions:
G 0002/88
G 0006/88
G 0009/91
T 0296/87
Citing decisions:
T 0356/01
T 1814/06

Source: http://www.epo.org/law-practice/case-law-appeals/recent/t990308eu1.html

Date retrieved: 17 May 2021

5 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

Case Law Book: I Patentability

Case Law of the Enlarged Board

General Case Law